[HTML][HTML] Gastrointestinal Behçet's disease: a review

W Skef, MJ Hamilton, T Arayssi - World Journal of …, 2015 - ncbi.nlm.nih.gov
Behçet's disease (BD) is an idiopathic, chronic, relapsing, multi-systemic vasculitis
characterized by recurrent oral and genital aphthous ulcers, ocular disease and skin lesions …

Behcet's disease: review with emphasis on dermatological aspects

MAR Scherrer, VB Rocha, LC Garcia - Anais brasileiros de …, 2017 - SciELO Brasil
Behçet's disease is a systemic vasculitis characterized by attacks of acute inflammation,
which can affect almost every vascularized area of the body. There is a close correlation …

European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis–endorsed by the European Academy of Neurology

JM Ferro, MG Bousser, P Canhão… - European stroke …, 2017 - journals.sagepub.com
The current proposal for cerebral venous thrombosis guideline followed the Grading of
Recommendations, Assessment, Development, and Evaluation system, formulating relevant …

Apremilast for Behçet's syndrome—a phase 2, placebo-controlled study

G Hatemi, M Melikoglu, R Tunc… - … England Journal of …, 2015 - Mass Medical Soc
Background Oral ulcers, the hallmark of Behçet's syndrome, can be resistant to conventional
treatment; therefore, alternative agents are needed. Apremilast is an oral phosphodiesterase …

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: multicenter study of 124 patients

H Vallet, S Riviere, A Sanna, A Deroux, G Moulis… - Journal of …, 2015 - Elsevier
Objective To report the efficacy and safety of anti-TNF agents in patients with severe and/or
refractory manifestations of Behçet's disease (BD). Methods We performed a multicenter …

Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease

A Le Joncour, R Martos, S Loyau, N Lelay… - Annals of the …, 2019 - ard.bmj.com
Objectives Behçet's disease (BD) is a chronic systemic vasculitis. Thrombosis is a frequent
and life-threatening complication. The pathogenesis of BD is poorly understood and …

Behçet's disease: How to diagnose and treat vascular involvement

E Seyahi - Best practice & research Clinical rheumatology, 2016 - Elsevier
Behçet's disease is a multisystem disorder with unknown etiology and a unique geographic
distribution. The disease is characterized by recurrent skin–mucosa lesions and sight …

Behçet disease: new aspects

I Bulur, M Onder - Clinics in dermatology, 2017 - Elsevier
Behçet disease is currently considered an “autoinflammatory disease” triggered by infection
and environmental factors in genetically predisposed individuals. Although the disease is …

Immunosuppressants reduce venous thrombosis relapse in Behçet's disease

AC Desbois, B Wechsler, M Resche‐Rigon… - Arthritis & …, 2012 - Wiley Online Library
Objective To investigate and describe the long‐term outcome of venous thrombosis in
patients with Behçet's disease (BD). Methods In a retrospective cohort of 807 BD patients, a …

Update on the therapy of Behçet disease

Z Saleh, T Arayssi - Therapeutic advances in chronic …, 2014 - journals.sagepub.com
Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing
and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and …